Evaluation of risk factors for thrombosis after ultrasound-guided internal jugular vein catheterization in patients with lymphoma

Abstract

We conducted a retrospective analysis of clinical and ultrasound data from 112 lymphoma patients who underwent ultrasound-guided internal jugular vein catheterization to investigate the risk factors for venous thrombosis. The procedure, which is safe and convenient for long-term chemotherapy, can be compromised by the development of venous thrombosis, impacting patient quality of life. Patients were divided into two groups: those with thrombosis (thrombus group) and those without (no thrombus group), based on preoperative vascular ultrasound findings within the internal jugular vein. In the multiple logistic regression analysis models, the catheter diameter (OR=0.145, 95%CI: 0.032-0.660, P<0.05), FIB (OR=2.438, 95%CI: 1.306-4.552, P<0.05), and diabetes (OR=0.139, 95%CI: 0.026-0.754, P<0.05) were found to have independent associations with thrombosis in lymphoma patients who underwent ultrasound-guided internal jugular vein catheterization (all P<0.05). The area under the curve was 0.816, indicating good predictive accuracy of the nomogram model for assessing the risk of thrombosis.